Skip to main content

Day: August 16, 2021

Northview Canadian High Yield Residential Fund Announces August Distribution

Not for distribution to U.S. newswire services or for dissemination in the United States. TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Northview Canadian High Yield Residential Fund (the “Fund”) today announced its August 2021 cash distribution amounts on its outstanding Class A Units, Class C Units and Class F Units Class (collectively, the “Units”), payable on September 15, 2021 to holders of Units of record at August 31, 2021. The distribution amounts will be as follows:C$0.10476 per Class A Unit, representing approximately C$1.26 per Unit on an annualized basis; C$0.11056 per Class C Unit, representing approximately C$1.33 per Unit on an annualized basis; C$0.10807 per Class F Unit, representing approximately C$1.30 per Unit on an annualized basis;About Northview Canadian High Yield Residential Fund The Fund is a “closed-end...

Continue reading

CAPREIT Announces Increased August 2021 Distribution

TORONTO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Canadian Apartment Properties Real Estate Investment Trust (“CAPREIT”) (TSX – CAR.UN) announced today its August 2021 monthly distribution in the amount of $0.12083 per Unit (or $1.45 on an annualized basis). The August distribution will be payable on September 15, 2021 to Unitholders of record on August 31, 2021. “We were pleased to announce a 5% increase in monthly cash distributions last week, a reflection of our strong performance through the pandemic, our confidence in the future, and our commitment to enhancing long-term Unitholder value,” Mark Kenney, President and CEO stated. As usual, to encourage participation and reward our loyal Unitholders, investors registered in our Distribution Reinvestment Plan will continue to receive an additional amount equal to 5% of their distributions...

Continue reading

Mydecine Reports Second Quarter 2021 Financial Results and Provides Business Update

Groundbreaking Progress in Clinical Trial and Drug Discovery Programs Enhanced Technology Offering with Mindleap 2.0, its Digital Health Platform to Support the Adoption of Psychedelics into Mental Health and Inner Wellness DENVER, Aug. 16, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company’), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today reported its financial results for the second quarter ended June 30, 2021 and provided a business update. “Mydecine has continued to make groundbreaking progress and novel discoveries in its psilocybin compound research and psychedelic-assisted drug development in the second quarter of 2021. We identified our...

Continue reading

Deep Down Announces Second Quarter 2021 Results

HOUSTON, Aug. 16, 2021 (GLOBE NEWSWIRE) — Deep Down, Inc. (OTCQB: DPDW) (“Deep Down” or the “Company”), a specialist in offshore energy equipment and services, today reported results for its second quarter ended June 30, 2021. Deep Down will hold a conference call tomorrow, Tuesday, August 17, 2021 at 10:00 am Eastern Time to review its results and outlook (call details below). Deep Down at a Glance:Share Price†: $0.72 Cash*: $4.1M52-Week Range: $0.34 – $0.80 Book Value*: $8.8MShares Out.†: 12.4M Price / Book Value: 1.0xMarket Cap†: $8.9M TTM Revenue: $15.1M*As of 12/31/20; †As of 8/13/21      Charles Njuguna, Deep Down’s CEO, commented, “Deep Down’s results for the second quarter of 2021 represent continued momentum for the company as we continue to capitalize on opportunities created by increased levels...

Continue reading

Ensysce Biosciences Reports Second Quarter 2021 Financial Results and Recent Corporate Updates

SAN DIEGO, Aug. 16, 2021 (GLOBE NEWSWIRE) — Ensysce Biosciences, Inc. (“Ensysce” or the “Company”) (NASDAQ: ENSC, OTC: ENSCW), a clinical-stage biotech company with proprietary technology platforms to reduce the economic and social burden of prescription drug abuse and overdose, today reported financial results for the second quarter of 2021 and recent corporate updates. “In the second quarter, we successfully closed our merger with Leisure Acquisition Corp., providing us with financial resources to advance our lead clinical programs and focus on expanding our pipeline of products in the pain, opioid use disorder (OUD) and ADHD space as a publicly listed company,” said Dr. Lynn Kirkpatrick, CEO of Ensysce Biosciences. “We currently have two technology platforms, TAAP and MPAR™, with three clinical-stage product candidates. Our...

Continue reading

VERB Continues SaaS Recurring Revenue Growth Year-Over-Year and Quarter-Over-Quarter in Q2 2021 Filing

SaaS recurring revenue grew 26% year over year and 10% sequentially 3 New ‘Hyper Growth’ Products released in Q2 including:verbMAIL video email solution for Microsoft Outlook – Gmail version coming powerful Attribution feature added to verbLIVE creating an affiliate marketing component, increasing total addressable market exponentially PULSE, an AI/BI-based feature set that tracks prospect interactions then educates salespeople while it automates the selling processVERB Marketplace [codename], an online destination for livestream shopping, is in active beta testing with multiple retailersNEWPORT BEACH, Calif. and SALT LAKE CITY, Aug. 16, 2021 (GLOBE NEWSWIRE) — Verb Technology Company, Inc. (Nasdaq: VERB) (“VERB” or the “Company”), the leader in interactive video-based sales enablement applications,...

Continue reading

Reservoir Media, Inc. Files Form 8-K With First Quarter Fiscal 2022 Financial Results

First quarter fiscal 2022 financial results highlighted by 23% increase in revenue and strong execution against strategic growth priorities NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) — Reservoir Media, Inc. (NASDAQ: RSVR) (“Reservoir” or the “Company”), an award-winning independent music company, today has filed an amendment no. 2 to the Current Report on Form 8-K (the “Form 8-K”), which includes financial results for the first quarter ended June 30, 2021 (the “first quarter 2022”). The Form 8-K can be found in the Company’s filings with the Securities and Exchange Commission (the “SEC”) at www.sec.gov, which are also included in the Investor Relations section of the Company’s website. Highlights and Recent DevelopmentsTotal revenues for the year ended March 31, 2021 were $81.8 million, which represented an increase of 28% year-over-year,...

Continue reading

Staffing 360 Solutions Reports Second Quarter and Six-Month 2021 Results

Return to Net Income Positive NEW YORK, Aug. 16, 2021 (GLOBE NEWSWIRE) — Staffing 360 Solutions, Inc. (NASDAQ: STAF), a company executing an international buy-integrate-build strategy through the acquisition of staffing organizations in the United States and the United Kingdom, today announced its Fiscal 2021 second quarter and six-month financial results. Q2 2021 OverviewRevenue increased 16.5% to $50.5 million from $43.4 million in Q2 ’20 (22.9% increase excluding the disposal of firstPRO)                  Gross profit increased 19.4% to $9.0 million from $7.6 million in Q2 ’20 (36.8% increase excluding the disposed business)                             Loss from operations narrowed to ($1.1 million) as compared with a loss from operations of ($1.5 million) in Q2 ’20 – a result of strong execution in all of our businesses...

Continue reading

Stem Holdings, Inc. d/b/a Driven By Stem Announces Record Sales and Gross Margin for the Third Quarter

Gross Sales Increase of 104% to US$12.4 Million Year-over-Year Net Sales Increase of 103% to US$10.6 Million Year-over-Year Gross Margin Improved 7.6% Year-over-Year BOCA RATON, Fla., Aug. 16, 2021 (GLOBE NEWSWIRE) — Stem Holdings, Inc. d/b/a Driven by Stem (OTCQX: STMH) (CSE: STEM) (the “Company” or “Stem“), the first multi-state, vertically integrated Farm-to-Home™ (F2H) cultivation and technology omnichannel cannabis company featuring a proprietary Delivery-as-a-Service (DaaS) marketplace platform, today reported results for the third fiscal quarter ended June 30, 2021. Stem reported third quarter record gross sales of US$12.4 million and net sales of US$10.6 million, a 104% increase and 103% increase, respectively, over the prior year’s US$6.1 million gross sales and US$5.2 million net sales. Gross margin...

Continue reading

Identity & Access Management (IAM) Solutions Provider BIO-key Reports Increased Revenue and Reduced Net Loss on Growth in Cloud ID-as-a-Service (IDaaS); Investor Call Tomorrow at 10am ET

WALL, N.J., Aug. 16, 2021 (GLOBE NEWSWIRE) — BIO-key International, Inc. (Nasdaq: BKYI), an innovative provider of biometric and multi-factor identity and access management (IAM) solutions for strong, convenient user authentication and large-scale identity applications, today reported results for its second quarter and six months ended June 30, 2021 (Q2’21). BIO-key will host a conference call tomorrow at 10:00 a.m. ET (details below) to review its results and outlook. Highlights: Q2 Customer WinsCalifornia Community College System Expanded to 55+ Customers with Addition of Mendocino College Migration to PortalGuard® Identity-as-a-Service (IDaaS) Platform Accelerates as Higher-Education and Enterprise Customers Choose Cloud-Based Identity ManagementQ2 Channel Alliance Partner Program ExpansionAdded Kenya-Based Cyber Security...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.